Casandra
Casandra Test Code QD27248Version 1 (DRAFT)
Performing Lab
Recombx® CV2 Autoantibody Test
Also known as: CRMP-5, CRMS
Clinical Use
Order TestUse
Anti‑CV2 (also known as CRMP5) autoantibodies are markers of paraneoplastic neurological syndromes, aiding in the diagnosis of immune-mediated neurological disorders, especially in patients presenting with rapidly progressive neurologic symptoms.
Special Instructions
Not provided.
Limitations
Not provided.
Test Details
Methodology
Immunoassay (Multiplex Protein Panel)
Biomarkers
CV2 (CRMP5) autoantibody
ProteinAutoantibody detection • Other • Binary (Detected / Not Detected)
Result Turnaround Time
4-7 days
Related Documents
For more information, please review the documents below
Specimen Requirements
Specimen
Serum
Volume
2 mL
Minimum Volume
0.5 mL
Container
plastic vial
Collection Instructions
Collect specimen in a red top or SST tube. Centrifuge, aliquot serum into a plastic vial and refrigerate.
Storage Instructions
Refrigerated
Related Tests
Other tests from different labs that may be relevant
CV2 Antibody, IgG by CBA-IFA With Reflex to Titer, Serum
ARUP Laboratories
CV2 Antibody, IgG by CBA-IFA With Reflex to Titer, CSF
ARUP Laboratories
Collapsin Response-Mediator Protein-5-IgG, Western Blot, Serum
Mayo Clinic Lab
Autoimmune Vision Loss Panel, Serum
ARUP Laboratories
Collapsin Response-Mediator Protein-5-IgG, Western Blot, Spinal Fluid
Mayo Clinic Lab
Collapsin Response-Mediator Protein-5 (CRMP-5) Neuronal IgG Titer, Spinal Fluid
Mayo Clinic Lab
Collapsin Response-Mediator Protein-5 (CRMP-5) Neuronal IgG Titer, Serum
Mayo Clinic Lab
Paraneoplastic, Autoantibody Profile
Labcorp
Paraneoplastic Reflexive Panel, CSF
ARUP Laboratories
Autoimmune Neurology/Comprehensive Paraneoplastic Profile, Spinal Fluid
Labcorp